Cargando…

High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Xue, Xiaotong, Mi, Zihao, Wang, Zhenzhen, Pang, Zheng, Liu, Hong, Zhang, Furen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245327/ https://www.ncbi.nlm.nih.gov/pubmed/32454066 http://dx.doi.org/10.1016/j.jid.2020.05.087

Ejemplares similares

ACE2 Expression on the Keratinocytes and SARS-CoV-2 Percutaneous Transmission: Are they Related?
por: Zhu, Ruixuan, et al.
Publicado: (2021)

Sars-CoV-2 and black population: ACE2 as shield or blade?
por: Vinciguerra, Mattia, et al.
Publicado: (2020)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy
por: Gengler, Carole, et al.
Publicado: (2021)

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
por: Jackson, Daniel J., et al.
Publicado: (2020)

SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
por: Shen, Shu, et al.
Publicado: (2021)

Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses
por: Li, Fei-Feng, et al.
Publicado: (2020)

Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors
por: XU, Xiao Gang, et al.
Publicado: (2020)

ACE2‐enriched extracellular vesicles enhance infectivity of live SARS‐CoV‐2 virus
por: Tey, Sze Keong, et al.
Publicado: (2022)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction
por: Ren, Yongwen, et al.
Publicado: (2022)

Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
por: Lim, Key-Hwan, et al.
Publicado: (2020)

Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice
por: Zhu, Teng-Yu, et al.
Publicado: (2021)

Could anti-ACE2 antibodies alter the results of SARS-CoV-2 Ab neutralization assays?
por: Tobes, Raquel, et al.
Publicado: (2022)

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein
por: Sagar, Satish, et al.
Publicado: (2021)

Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
por: Ni, Xiaotian, et al.
Publicado: (2020)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice
por: van Oosten, Linda, et al.
Publicado: (2022)

Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
por: Gharebaghi, Reza, et al.
Publicado: (2022)

A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Response Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
por: Shakhsi-Niaei, Mostafa, et al.
Publicado: (2022)

Skin manifestations associated with the new coronavirus SARS-CoV-2 disease()
por: Redondo-Sendino, Áurea, et al.
Publicado: (2020)

Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease
por: Magierska, Agata, et al.
Publicado: (2022)

Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes
por: Robinson, Emma L., et al.
Publicado: (2020)

Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
por: Li, Mengjiao, et al.
Publicado: (2022)

Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding
por: Miao, Lu, et al.
Publicado: (2022)

Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19
por: Li, Xueting, et al.
Publicado: (2020)

Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection
por: Guo, Liang, et al.
Publicado: (2020)

Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2
por: Tang, Yan-Dong
Publicado: (2021)

RBD-ACE2 binding properties in five SARS-CoV-2 variants of concern with new perspectives in the design of pan-coronavirus peptide inhibitors
por: Yan, Fangfang, et al.
Publicado: (2023)

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
por: Li, Shuwei, et al.
Publicado: (2022)

Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis
por: Krueger, James G., et al.
Publicado: (2021)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
por: De Cauwer, Harald
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply
por: Albini, Adriana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2gvltchlurov466bvrmisvra44